반응식
C([CH:5]1[CH2:10][CH2:9][CH:8]([C:11]2[CH:12]=[C:13]([NH:17][C:18](=[O:29])[CH2:19][C:20]3[CH:25]=[CH:24][C:23]([OH:26])=[C:22]([O:27][CH3:28])[CH:21]=3)[CH:14]=[CH:15][CH:16]=2)[CH2:7][CH2:6]1)(C)(C)C.[OH:30][C:31]1C=CC(CC(NC2C=CC=C(C3C=CC=CC=3)C=2)=O)=C[C:32]=1OC>>[C:31]([O:26][C:23]1[CH:24]=[CH:25][C:20]([CH2:19][C:18]([NH:17][C:13]2[CH:14]=[CH:15][CH:16]=[C:11]([C:8]3[CH:7]=[CH:6][CH:5]=[CH:10][CH:9]=3)[CH:12]=2)=[O:29])=[CH:21][C:22]=1[O:27][CH3:28])(=[O:30])[CH3:32]참가 물질
3
실험 절차
Instead of N-[3-(4-tert-butylcyclohexan-1-yl)phenyl]-4-hydroxy-3-methoxyphenylacetamide in Example 69, the compound of Example 35 is treated in a similar manner to Example 69 to give the desired compound.
출처 및 근거
- ORD 기록
- ord-f0de59c17766482bb51f793fa0da73f0
- 출처 데이터셋
- uspto-grants-2006_08
- 특허 번호
- US07084176B2
연결된 노트
불러오는 중…